SUNNYVALE, Calif., Oct. 28, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it will hold a conference call and audio webcast to discuss its financial results for the third quarter of 2014 on Tuesday, November 4, 2014 at 4:30 P.M. Eastern Time. The financial results for the third quarter of 2014 will be released after markets close on the day of the conference call.
Interested parties may listen to the live teleconference by calling 877-303-7908 toll free from the U.S. or +1-678-373-0875 internationally. Individuals may access the live audio webcast by visiting: http://ir.pharmacyclics.com/events.cfm.
A webcast replay will be available on the Pharmacyclics website for 30 days following the call.
About Pharmacyclics®
Pharmacyclics, Inc. (NASDAQ: PCYC) is a biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company’s mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify and control promising product candidates based on scientific development and administrative expertise, develop its products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.
Pharmacyclics markets IMBRUVICA® (ibrutinib) in the United States and has three product candidates in clinical development and several preclinical molecules in lead optimization. The Company is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization. Pharmacyclics is headquartered in Sunnyvale, CA. To learn more, visit www.pharmacyclics.com.
SOURCE Pharmacyclics, Inc.
Help employers find you! Check out all the jobs and post your resume.
